NovoCure Limited Share Price
NASDAQ: NVCR | Small CapNovoCure Limited Stock Performance
NovoCure Limited Share Price Today
As of 30 October 2026, NovoCure Limited's share price is $13.12. The stock opened at $12.71, compared to its previous close of $14.16. During today's trading session, NovoCure Limited's share price traded between $11.91 and $13.83, with an average price of $12.87. Over the past 52 weeks, the stock has recorded a high of $21.31 and a low of $9.83. In terms of performance, NovoCure Limited's share price has declined by 13.69% over the last six months and is up 2.54% on a year-on-year basis.
NovoCure Limited Share Price Chart
NovoCure Limited Quarterly Profit & Loss
All figures in USD
NovoCure Limited Annual Profit & Loss
All figures in USD
About NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
NovoCure Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $15.88 | $13.07 | -18.18% |
Sep 2026 | $17.51 | $15.98 | -11.17% |
Aug 2026 | $15.05 | $17.99 | +21.14% |
Jul 2026 | $15.38 | $14.85 | -1.75% |
Jun 2026 | $17.18 | $15.12 | -11.30% |
May 2026 | $15.40 | $17.04 | +12.14% |
Apr 2026 | $11.08 | $15.20 | +39.28% |
Mar 2026 | $13.63 | $10.91 | -20.10% |
Feb 2026 | $12.25 | $13.65 | +9.94% |
Jan 2026 | $12.97 | $12.42 | -3.80% |
Dec 2025 | $12.12 | $12.91 | +0.86% |
Nov 2025 | $12.77 | $12.80 | +0.08% |